Nexentis Technologies Inc.

Name: Nexentis Technologies Inc. standardized financial statements, quarterly
Creator: Listed

NXTSNasdaqCIK 1789192HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$2.0k, Q3 FY2025

Operating income−$1.9m, Q2 FY2026

Net income−$11.1m, Q2 FY2026

Nexentis Technologies Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	not reported	not reported	not reported
Cost of revenue	$m	0.0	(0.0)	0.0	0.0	0.1	0.1	0.0	0.0	0.0	not reported	not reported	not reported
Gross profit	$m	(0.0)	0.1	0.0	0.0	(0.1)	0.1	0.1	(0.0)	0.0	not reported	not reported	not reported
Research and development	$m	1.7	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.4
Operating income	$m	(2.9)	(2.1)	(0.9)	(0.8)	(1.4)	(0.2)	(0.5)	(2.6)	(1.3)	0.5	(8.2)	(1.9)
Income tax	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	(0.0)	(0.0)
Net income	$m	(2.4)	(1.7)	(0.8)	(0.8)	(2.3)	(1.4)	(1.2)	(4.5)	0.4	1.3	(6.6)	(11.1)
Diluted EPS	$ per share	(1.78)	not reported	(0.26)	(0.23)	(0.39)	not reported	(85.25)	(44.26)	0.97	not reported	(10.74)	(13.66)
Basic EPS	$ per share	(1.78)	not reported	(0.26)	(0.23)	(14.27)	not reported	(18.00)	(44.26)	0.45	not reported	(10.74)	(13.66)

Balance sheet

Cash and equivalents$7.6m, Q2 FY2026

Shareholders' equity$1.9m, Q2 FY2026

Nexentis Technologies Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	1.9	4.4	3.5	4.5	2.7	1.9	2.7	3.1	6.0	3.8	4.3	7.6
Current assets	$m	2.8	5.5	4.4	5.5	3.4	3.5	4.3	5.0	8.7	6.0	8.2	10.4
Total assets	$m	5.3	7.2	6.3	7.5	5.8	5.5	7.4	7.8	11.0	20.4	16.4	18.7
Current liabilities	$m	0.6	0.8	0.6	1.6	0.5	0.9	1.0	1.1	2.1	1.4	1.7	2.8
Total liabilities	$m	0.6	0.8	0.6	1.6	0.5	0.9	3.7	2.2	2.4	4.7	3.5	16.9
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	0.0	1.2	1.2	1.4	not reported	not reported
Short-term borrowings	$m	not reported	not reported	not reported	1.2	not reported	not reported	not reported	not reported	1.1	0.7	0.4	0.2
Shareholders' equity	$m	4.6	6.5	5.8	6.0	5.4	4.7	3.9	5.8	8.9	16.0	13.0	1.9

Cash flow

Operating cash flow−$539.0k, Q2 FY2026

Capital expenditure$1.0k, Q2 FY2026

Nexentis Technologies Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(624)	(975)	(1,008)	(1,028)	(891)	(492)	(809)	(528)	(974)	(1,497)	(1,419)	(539)
Capital expenditure	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	71.0	1.0

Diluted shares (weighted)816,136, Q2 FY2026

Nexentis Technologies Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	k shares	558	696	1,027	1,331	2,961	3,409	5,820	102	102	967	613	816

Shares outstanding: 1.45m at Aug 13, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.